Name |
|
Lawrence Kwong |
Organization |
|
UT MD Anderson Cancer Center |
Can you tell us a bit about yourself? |
|
Have been a PI for 6 years, was the TCGA co-chair for cholangio. |
Can you share one or two of your specific research interests? |
|
Chromatin modifiers, biomarkers |
Why did you decide to specialize in hepatobiliary cancers? |
|
Understudied cancer type, fascinating mutation landscape |
Can you describe one of the unforgettable moments in your patients care or research that has impacted your career? |
|
Meeting patients and caretakers at the Cholangio Foundation Annual Meeting, important to hear their stories and concerns |
Can you tell us one thing collaboration with colleagues could accomplish that you could not accomplish on your own? |
|
Patient sample acquisition and expert analysis |
If you had access to one resource that would move your research forward, what would that resource be? |
|
Access to broader mouse models, GEMMS, PDX, etc. |
How did you learn about the Cholangiocarcinoma Foundation? |
|
Annual Meeting |
Can you tell us why you became a member of the ICRN? |
|
To connect with top researchers and physicians |